Abstract
SBP is a common, life-threatening complication of cirrhosis that imposes a substantial and growing healthcare cost burden. Treatment guidelines from the American Association for the Study of Liver Diseases recommend albumin administration in conjunction with antibiotics for SBP management due to albumin’s demonstrated clinical efficacy and safety. We examined the relationship between albumin infusion timing and total hospitalization cost among cirrhotic inpatients who developed SBP during hospitalization.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
